Value of genetic testing in the otological approach for sensorineural hearing loss

Keio Journal of Medicine

Volumn 58, Issue 4, 2009, Pages 216-222

  Matsunaga, Tatsuo ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Cochlea; Deafness gene; Hereditary hearing loss; Inner ear

Indexed keywords

3 NITROPROPIONIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; MITOCHONDRIAL RNA; RIBOSOME RNA;

ALPORT SYNDROME; APOPTOSIS; AUDIOLOGY; CELL DAMAGE; CLINICAL FEATURE; COCHLEA; COCHLEA PROSTHESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE MODEL; DNA FLANKING REGION; DNA SEQUENCE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HEARING AID; HEARING IMPAIRMENT; HUMAN; INNER EAR; INNER EAR DISEASE; KIDNEY BIOPSY; LANGUAGE DEVELOPMENT; MEDICAL PRACTICE; MUTATIONAL ANALYSIS; NEWBORN SCREENING; NONHUMAN; PERCEPTION DEAFNESS; PREDICTION; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SPEECH DEVELOPMENT; STEM CELL TRANSPLANTATION; X CHROMOSOME LINKED DISORDER;

GENETIC TESTING; HEARING LOSS, SENSORINEURAL; HUMANS;

EID: 75149192021     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.58.216     Document Type: Review

References (26)

1. Smith RJ, Bale JF Jr, White KR: Sensorineural hearing loss in children. Lancet 2005; 365: 879-890
2. Morton CC, Nance WE: Newborn hearing screening-a silent revolution. N Engl J Med 2006; 354: 2151-2164
3. Willems PJ: Genetic causes of hearing loss. N Engl J Med 2000; 342: 1101-1109
4. Kochhar A, Hildebrand MS, Smith RJ: Clinical aspects of hereditary hearing loss. Genet Med 2007; 9: 393-408
5. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS,Cortopassi GA, Jaber L, Rotter JI, Shohat M, Fischel-Ghodsian N: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993; 4: 289-294
6. Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D' Agruma L, Mansfield E, Rappaport E, Govea N, Milà M, Zelante L, Gasparini P: Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998; 351: 394-398
7. Kelley PM, Harris DJ, Comer BC, Askew JW, Fowler T, Smith SD, Kimberling WJ: Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive(DFNB1) hearing loss. Am J Hum Genet 1998; 62: 792-729
8. Snoeckx RL, Huygen PL, Feldmann D, Marlin S, Denoyelle F, Waligora J,Mueller-Malesinska M, Pollak A, Ploski R, Murgia A, Orzan E, Castorina P, Ambrosetti U, Nowakowska-Szyrwinska E, Bal J, Wiszniewski W, Janecke AR, Nekahm-Heis D, Seeman P, Bendova O, Kenna MA, Frangulov A, Rehm HL, Tekin M,Incesulu A, Dahl HH, du Sart D, Jenkins L, Lucas D, Bitner-Glindzicz M, AvrahamKB, Brownstein Z, del Castillo I, Moreno F, Blin N, Pfister M, Sziklai I, Toth T,Kelley PM, Cohn ES, Van Maldergem L, Hilbert P, Roux AF, Mondain M, Hoefsloot LH,Cremers CW, Löppönen T, Löppönen H, Parving A, Gronskov K, Schrijver I, Roberson J, Gualandi F, Martini A, Lina-Granade G, Pallares-Ruiz N, Correia C, Fialho G,Cryns K, Hilgert N, Van de Heyning P, Nishimura CJ, Smith RJ, Van Camp G: GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005; 77: 945-957
9. Pandya A, Arnos KS, Xia XJ, Welch KO, Blanton SH, Friedman TB, Garcia Sanchez G, Liu MD XZ, Morell R, Nance WE: Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med 2003; 5: 295-303
10. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E,Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate transporter gene(PDS). Nat Genet 1997; 17: 411-422
11. Pryor SP, Madeo AC, Reynolds JC, Sarlis NJ, Arnos KS, Nance WE, Yang Y, Zalewski CK, Brewer CC, Butman JA, Griffith AJ: SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 2005; 42: 159-165
12. Matsunaga T, Kumanomido H, Shiroma M, Goto Y, Usami S: Audiological features and mitochondrial DNA sequence in a large family carrying mitochondrial A1555G mutation without use of aminoglycoside. Ann Otol Rhinol Laryngol 2005; 114: 153-160
13. Chinnery PF, Elliott C, Green GR, Rees A, Coulthard A, Turnbull DM, Griffiths TD: The spectrum of hearing loss due to mitochondrial DNA defects. Brain 2000; 123 (Pt 1): 82-92
14. Matsunaga T, Kumanomido H, Shiroma M, Ohtsuka A, Asamura K, Usami S: Deafness due to A1555G mitochondrial mutation without use of aminoglycoside. Laryngoscope 2004; 114: 1085-1091
15. Kennedy CR, McCann DC, Campbell MJ, Law CM, Mullee M, Petrou S, Watkin P, Worsfold S, Yuen HM, Stevenson J: Language ability after early detection of permanent childhood hearing impairment. N Engl J Med 2006; 354: 2131-2141
16. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL: Language of early- and later-identified children with hearing loss. Pediatrics 1998; 102: 1161-1171
17. Matsunaga T, Hirota E, Bito S, Niimi S, Usami S: Clinical course of hearing and language development in GJB2 and non-GJB2 deafness following habilitation with hearing aids. Audiol Neurootol 2006; 11: 59-68
18. Usami S, Abe S, Kasai M, Shinkawa H, Moeller B, Kenyon JB, Kimberling WJ: Genetic and clinical features of sensorineural hearing loss associated with the 1555 mitochondrial mutation. Laryngoscope 1997; 107: 483-490
19. Gubler MC: Diagnosis of Alport syndrome without biopsy? Pediatr Nephrol 2007; 22: 621-625
20. Yasunaga S, Grati M, Cohen-Salmon M, El-Amraoui A, Mustapha M, Salem N, El-ZirE, Loiselet J, Petit C: A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 1999; 21: 363-369
21. Rouillon I, Marcolla A, Roux I, Marlin S, Feldmann D, Couderc R, Jonard L,Petit C, Denoyelle F, Garabédian EN, Loundon N: Results of cochlear implantation in two children with mutations in the OTOF gene. Int J Pediatr Otorhinolaryngol 2006; 70: 689-696
22. Rodríguez-Ballesteros M, Reynoso R, Olarte M, Villamar M, Morera C, SantarelliR, Arslan E, Medá C, Curet C, Völter C, Sainz-Quevedo M, Castorina P, Ambrosetti U, Berrettini S, Frei K, Tedín S, Smith J, Cruz Tapia M, Cavallé L, Gelvez N, Primignani P, Gómez-Rosas E, Martín M, Moreno-Pelayo MA, Tamayo M, Moreno-Barral J, Moreno F, del Castillo I: A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene (OTOF) in subjects with nonsyndromic hearing impairment and auditory neuropathy. Hum Mutat 2008; 29: 823-831
23. Hoya N, Okamoto Y, Kamiya K, Fujii M, Matsunaga T: A novel animal model of acute cochlear mitochondrial dysfunction. Neuroreport 2004; 15: 1597-1600
24. Okamoto Y, Hoya N, Kamiya K, Fujii M, Ogawa K, Matsunaga T: Permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by degeneration of the lateral wall of the cochlea. Audiol Neurootol 2005; 10: 220-233
25. Mizutari K, Matsunaga T, Kamiya K, Fujinami Y, Fujii M, Ogawa K: Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction. J Neurosci Res 2008; 86: 215-222
26. Kamiya K, Fujinami Y, Hoya N, Okamoto Y, Kouike H, Komatsuzaki R, Kusano R, Nakagawa S, Satoh H, Fujii M, Matsunaga T: Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes. Am J Pathol 2007; 171: 214-226